As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget COVID-19, monkeypox and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and

Related Keywords

United States ,Salt Lake ,California ,Philadelphia ,Pennsylvania ,Oregon ,Stanford Medical Center ,Temple University Hospital ,San Francisco ,Americans ,America ,David Shlaes ,Todd Young ,Rebecca Clausen ,Martha Sharan ,Kevin Outterson ,Neil Clancy ,Jason Gallagher ,Michael Bennet ,Sameer Kadri ,Dominic Chan ,Minh Hong Nguyen ,Molly Pam ,Emily Spivak ,Sarah Doernberg ,Ted Schroeder ,Centers For Disease ,University Of California ,Legacy Health ,World Health Organization ,University Of Utah ,Boston University ,San Francisco Medical Center ,Veterans Affairs Pittsburgh Healthcare System ,Infectious Diseases Society Of America ,Operation Warp Speed ,Disease Control ,California San Francisco Medical ,National Institutes ,Health Clinical Center ,Critical Care Medicine ,Iterum Therapeutic ,Spero Therapeutics ,New England Journal ,Lake City ,Infectious Diseases Society ,Veterans Affairs Pittsburgh Healthcare ,Nation And World ,Op Stories ,